BFM 89.9
The Business Station
Why A New TB Vaccine Is An Investment Worth Making
29 mins
·
16:00, 29 Mar 2024
·
Recommended
26 mins
23 mins
26 mins
Guest: Dr Allison Portnoy, Assistant Professor of Global Health, Boston University School of Public Health
It’s been more than 100 years since the BCG vaccine was first introduced as a significant tool in our fight against tuberculosis. While the BCG vaccine is still widely rolled out today, it is largely only effective among infants and young children, leaving adolescents and adults still vulnerable to developing TB. Worldwide, TB is one of the deadliest infectious diseases and leaves millions suffering from extended periods of ill-health and disability, especially in low- and middle-income countries. We speak to Dr Allison Portnoy, Assistant Professor of Global Health at the Boston University School of Public Health, to find out what difference a new TB vaccine could make, and how we can convince governments and pharmaceutical companies that this is an investment worth making.
Image credit: Shutterstock
Presenter: Lim Sue Ann
Producer: Lim Sue Ann
the bigger picture
health and living
globalhealththreats
tuberculosis
tb
vaccination
immunisation
vaccine equity
infectious disease
health economics
Share:
Recent episodes
0
Latest stories
Podcasts · Jan 15 · 12:00PM
Plowing Through Snow With The Haval H9
37 mins
Podcasts · Jan 15 · 11:00AM
If Walls Could Talk: The Story of Malaysian Street Art
34 mins
Podcasts · Jan 15 · 10:00AM
From Breaking Clocks To Saving The Environment
27 mins
Why A New TB Vaccine Is An Investment Worth Making
29 mins
·
16:00, 29 Mar 2024
Guest: Dr Allison Portnoy, Assistant Professor of Global Health, Boston University School of Public Health
It’s been more than 100 years since the BCG vaccine was first introduced as a significant tool in our fight against tuberculosis. While the BCG vaccine is still widely rolled out today, it is largely only effective among infants and young children, leaving adolescents and adults still vulnerable to developing TB. Worldwide, TB is one of the deadliest infectious diseases and leaves millions suffering from extended periods of ill-health and disability, especially in low- and middle-income countries. We speak to Dr Allison Portnoy, Assistant Professor of Global Health at the Boston University School of Public Health, to find out what difference a new TB vaccine could make, and how we can convince governments and pharmaceutical companies that this is an investment worth making.
Image credit: Shutterstock
Presenter: Lim Sue Ann
Producer: Lim Sue Ann
the bigger picture
health and living
globalhealththreats
tuberculosis
tb
vaccination
immunisation
vaccine equity
infectious disease
health economics
Share:
Recommended
May 10
·
23 minsWhat It Takes To Get Your Bread Right
May 9
·
26 minsConfronting Bullying In The Workplace
Download app
60,000 other podcasts in your hand
Recent episodes
0
Latest Stories
Podcasts · Jan 15 · 37 mins
Plowing Through Snow With The Haval H9
Podcasts · Jan 15 · 34 mins
If Walls Could Talk: The Story of Malaysian Street Art
Podcasts · Jan 15 · 27 mins
From Breaking Clocks To Saving The Environment